These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 4384520)
21. [Desensitization to salicylazosulfapyridine (Salazopyrin) in a patient with ulcerative colitis]. Chiba M; Murata M; Ihzuka M; Ohta H; Arakawa H; Masamune O; Ohkubo M Nihon Shokakibyo Gakkai Zasshi; 1986 Jan; 83(1):113-6. PubMed ID: 2871206 [No Abstract] [Full Text] [Related]
22. Multiple haematologic abnormalities associated with sulfasalazine. Wheelan KR; Cooper B; Stone MJ Ann Intern Med; 1982 Nov; 97(5):726-7. PubMed ID: 6127975 [No Abstract] [Full Text] [Related]
23. Salicylazosulfapyridine and male infertility. Heineman MJ; Dony JM; Rolland R Eur J Obstet Gynecol Reprod Biol; 1981 Nov; 12(5):297-303. PubMed ID: 6120861 [TBL] [Abstract][Full Text] [Related]
24. Sulfasalazine intolerance. A retrospective survey of the reasons for discontinuing treatment with sulfasalazine in patients with chronic inflammatory bowel disease. Nielsen OH Scand J Gastroenterol; 1982 Apr; 17(3):389-93. PubMed ID: 6127793 [TBL] [Abstract][Full Text] [Related]
25. Sulfasalazine-induced DRESS and severe agranulocytosis successfully treated by granulocyte colony-stimulating factor. Fathallah N; Slim R; Rached S; Hachfi W; Letaief A; Ben Salem C Int J Clin Pharm; 2015 Aug; 37(4):563-5. PubMed ID: 25854308 [TBL] [Abstract][Full Text] [Related]
26. Erythroderma and toxic epidermal necrolysis caused by to 5-aminosalacylic acid. Iemoli E; Piconi S; Ardizzone S; Bianchi Porro G; Raimond F Inflamm Bowel Dis; 2006 Oct; 12(10):1007-8. PubMed ID: 17012974 [No Abstract] [Full Text] [Related]
27. [Methemoglobin synthesis during azulfidine therapy]. Miller B; Engelhart A; Goebel KM; Schmidt J; Martini GA Verh Dtsch Ges Inn Med; 1971; 77():1326-30. PubMed ID: 4405361 [No Abstract] [Full Text] [Related]
28. [Side effects of azulfidine therapy]. Miller B Med Welt; 1976 Jul; 27(27):1334-5. PubMed ID: 8688 [No Abstract] [Full Text] [Related]